Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia by Mahesh Swaminathan, Jorge E. Cortes

Get full text

Population modeling of bosutinib exposure‐response in patients with newly diagnosed chronic phase chronic myeloid leukemia by May Garrett, Beverly Knight, Jorge E. Cortes, Michael W. Deininger

Get full text

A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase by Valentin García-Gutiérrez, Massimo Breccia, Elias Jabbour, Michael Mauro, Jorge E. Cortes

Get full text

Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysi... by Jorge E. Cortes, Tara L. Lin, Kobby Asubonteng, Stefan Faderl, Jeffrey E. Lancet, Thomas Prebet

Get full text

Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML by Jorge E. Cortes, Tara L. Lin, Geoffrey L. Uy, Robert J. Ryan, Stefan Faderl, Jeffrey E. Lancet

Get full text

Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review by Jorge E. Cortes, Jane F. Apperley, Daniel J. DeAngelo, Michael W. Deininger, Vamsi K. Kota, Philippe Rousselot, Carlo Gambacorti-Passerini

Get full text

Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia by Jorge E. Cortes, Marcos de Lima, Hervé Dombret, Elihu H. Estey, Sergio A. Giralt, Pau Montesinos, Christoph Röllig, Adriano Venditti, Eunice S. Wang

Get full text

Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV) by Lucia Masarova, C. Cameron Yin, Jorge E. Cortes, Marina Konopleva, Gautam Borthakur, Kate J. Newberry, Hagop M. Kantarjian, Carlos E. Bueso-Ramos, Srdan Verstovsek

Get full text

Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. by Jaroslav Jelinek, Vazganush Gharibyan, Marcos R H Estecio, Kimie Kondo, Rong He, Woonbok Chung, Yue Lu, Nianxiang Zhang, Shoudan Liang, Hagop M Kantarjian, Jorge E Cortes, Jean-Pierre J Issa

Get full text

Upwelling increases net primary production of corals and reef-wide gross primary production along the Pacific coast of Costa Rica by Ines eStuhldreier, Ines eStuhldreier, Celeste eSánchez-Noguera, Celeste eSánchez-Noguera, Florian eRoth, Florian eRoth, Jorge eCortés, Tim eRixen, Christian eWild, Christian eWild

Get full text

Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers by Nikhil Shri Sahajpal, Ashis K. Mondal, Harmanpreet Singh, Ashutosh Vashisht, Sudha Ananth, Daniel Saul, Alex R. Hastie, Benjamin Hilton, Barbara R. DuPont, Natasha M. Savage, Vamsi Kota, Alka Chaubey, Jorge E. Cortes, Ravindra Kolhe

Get full text

A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors... by Alejandro Zulbaran‐Rojas, Huei‐Kan Lin, Qiuling Shi, Loretta A. Williams, Binsah George, Guillermo Garcia‐Manero, Elias Jabbour, Susan O’Brien, Farhad Ravandi, William Wierda, Zeev Estrov, Gautam Borthakur, Tapan Kadia, Charles Cleeland, Jorge E. Cortes, Hagop Kantarjian

Get full text

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia by Prajwal Boddu, Gautam Borthakur, Mythili Koneru, Xuelin Huang, Kiran Naqvi, William Wierda, Prithviraj Bose, Elias Jabbour, Zeev Estrov, Jan Burger, Yesid Alvarado, April Deshmukh, Ami Patel, Antonio Cavazos, Lina Han, Jorge E. Cortes, Hagop Kantarjian, Michael Andreeff, Marina Konopleva

Get full text

Teledermatology for skin cancer screening in rural Georgia utilizing teledermoscopy and distance learning: An ongoing report by McKenzie E. Maloney, BS, Marisol Miranda-Galvis, DDS, MS, PhD, Brenda Santellano Juarez, MD, Kenza Mamouni, MBA, PhD, Lorriane Odhiambo, PhD, MPH, Samah Ibrahim, MBBS, K.M. Monirul Islam, PhD, Rhea-Beth Markowitz, PhD, Koosh Desai, MD, Harold Rabinovitz, MD, Kendall Buchanan, MD, Douglas Patten, MD, Loretta S. Davis, MD, Jorge E. Cortes, MD

Get full text

Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML by Musa Yilmaz, Mansour Alfayez, Courtney D. DiNardo, Gautam Borthakur, Tapan M. Kadia, Marina Y. Konopleva, Sanam Loghavi, Rashmi Kanagal-Shamanna, Keyur P. Patel, Elias J. Jabbour, Guillermo Garcia-Manero, Naveen Pemmaraju, Sherry A. Pierce, Issa Ghayas, Nicholas J. Short, Guillermo Montalban-Bravo, Koichi Takahashi, Rita Assi, Ahmad S. Alotaibi, Maro Ohanian, Michael Andreeff, Jorge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi, Naval G. Daver

Get full text